Stock Scorer

Bioforce Nanosciences Holdings, Inc. (BFNH)

Every figure this model derived for BFNH, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2019-12-31.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
cash 307 CashAndCashEquivalentsAtCarryingValue 2026-06-30
equity 2,303,308 StockholdersEquity 2026-06-30
revenue 17,774 Revenues 2019-12-31
sbc 158,000,000 ShareBasedCompensation 2020-09-30

The ratios

The figures themselves rather than their scores — what somebody looking up BFNH on one particular measure came for.

RatioValue
ev sales13156.09
operating margin-261.83
revenue growth8.98
revenue growth per share8.98
roic-1.6
rule of 40-252.86

Everything else this filing tags

70 more elements from BFNH's own XBRL that this model has no measure for, newest reading each, largest first. Nothing here is converted, added up or renamed — it is the filing's own element names and the filing's own numbers.

ElementNewestAs of PeriodsUnit
CommonStockSharesAuthorized900,000,0002026-06-30 70shares
RetainedEarningsAccumulatedDeficit-162,275,8462026-06-30 70USD
AdditionalPaidInCapitalCommonStock162,061,3052026-06-30 70USD
StockIssuedDuringPeriodValueIssuedForServices158,000,0002020-12-31 9USD
PreferredStockSharesAuthorized100,000,0002026-06-30 57shares
CommonStockSharesIssued33,549,0052026-06-30 70shares
CommonStockSharesOutstanding33,549,0052026-06-30 70shares
WeightedAverageNumberOfSharesOutstandingBasic33,532,8962026-06-30 50shares
WeightedAverageNumberOfDilutedSharesOutstanding33,532,8962026-06-30 44shares
WeightedAverageNumberOfShareOutstandingBasicAndDiluted29,271,7552021-12-31 48shares
RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings4,250,0002025-01-24 6shares
Assets2,388,0752026-06-30 70USD
LiabilitiesAndStockholdersEquity2,388,0752026-06-30 70USD
PrepaidExpenseCurrent2,153,2432026-06-30 23USD
OtherPrepaidExpenseCurrent2,108,3332026-06-30 1USD
ProfitLoss-1,173,3462025-09-30 28USD
GainsLossesOnExtinguishmentOfDebt802,0002026-06-30 6USD
NonoperatingIncomeExpense516,3342026-06-30 5USD
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest-380,0632026-06-30 32USD
OperatingExpenses380,0632026-06-30 84USD
OperatingIncomeLoss-372,1532025-09-30 29USD
CompensationExpenseExcludingCostOfGoodAndServiceSold249,5002026-06-30 78USD
NetIncomeLossAvailableToCommonStockholdersBasic238,6822026-06-30 16USD
DueToRelatedPartiesCurrent164,6812022-09-30 22USD
NetIncomeLoss136,2712026-06-30 104USD
GeneralAndAdministrativeExpense130,5632026-06-30 104USD
OperatingLossCarryforwardsValuationAllowance114,2002019-12-31 3USD
StockIssuedDuringPeriodSharesAcquisitions100,0002020-05-06 2shares
IncreaseDecreaseInAccruedSalaries89,2502026-06-30 52USD
Liabilities84,7672026-06-30 70USD
ProceedsFromRelatedPartyDebt65,0742025-12-31 48USD
DueFromBanks39,2602020-06-30 18USD
CommonStockValue33,5492026-06-30 70USD
DeferredTaxAssetsNet30,8552019-12-31 3USD
AccruedSalariesCurrentAndNoncurrent21,7502026-06-30 52USD
NetCashProvidedByUsedInFinancingActivities19,4132026-06-30 56USD
ProceedsFromRepaymentsOfRelatedPartyDebt17,4132026-06-30 4USD
CostOfRevenue13,4152019-12-31 23USD
IssuanceOfStockAndWarrantsForServicesOrClaims13,2552019-09-30 4USD
CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect-13,0302020-12-31 16USD
CurrentIncomeTaxExpenseBenefit12,5552019-12-31 6USD
AccountsPayableAndAccruedLiabilitiesCurrent12,2842026-06-30 66USD
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect-10,3552022-09-30 18USD
StockIssuedDuringPeriodValueConversionOfUnits8,0752024-12-31 12USD
AccountsReceivableNetCurrent5,9622019-09-30 12USD
IncreaseDecreaseInAccountsReceivable-5,7352019-12-31 17USD
OtherExpenses5,0002026-06-30 18USD
GrossProfit4,3602019-12-31 23USD
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities3,3422026-06-30 70USD
RepaymentsOfDebt1,5272025-06-30 2USD
ProceedsFromOtherEquity1,3392020-12-31 25USD
ConversionOfStockSharesIssued11,1672020-12-31 31shares
PaymentsToAcquireBusinessesGross1,0002020-05-06 27USD
Cash6052020-06-30 18USD
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect-4792026-06-30 31USD
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents3072026-06-30 72USD
ProceedsFromContributedCapital1002022-09-30 19USD
ProceedsFromContributionsFromParent1002022-09-30 1USD
StockIssuedDuringPeriodValueEmployeeBenefitPlan1002022-09-30 1USD
IncreaseDecreaseInPrepaidExpense-402022-12-31 39USD
SharesIssuedPricePerShare12021-12-31 7USD/shares
EarningsPerShareBasicAndDiluted-02021-12-31 48USD/shares
CommonStockParOrStatedValuePerShare02026-06-30 70USD/shares
PreferredStockParOrStatedValuePerShare02026-06-30 44USD/shares
EffectiveIncomeTaxRateContinuingOperations02019-12-31 6pure
IncomeTaxExpenseBenefit02019-12-31 4USD
PreferredStockSharesIssued02020-09-30 20shares
PreferredStockSharesOutstanding02021-12-31 22shares
EarningsPerShareBasic02026-06-30 52USD/shares
EarningsPerShareDiluted02026-06-30 44USD/shares

What to be careful about

What this model itself distrusts about BFNH's figures. Written by the derivation as it ran, not added afterwards.